What are the common concentrations and preparation methods for a compounded nasal spray containing 0.1% xylometazoline with added menthol or eucalyptol, and how can the water solubility issues of these additives be addressed?

What is a suitable formula for a moxifloxacin syrup for a patient with swallowing problems, given that the tablets may be crushed but the antibiotic is not listed on the SyrSpend list?

Would it be possible to suspend cefadroxil capsules in SyrSpend SF Cherry, for example?

Given that a doctor has prescribed Aculare anti-inflammatory eye drops, but Aculare, Dicloabak, Nevanac, and indomethacin are all unavailable, and the doctor emphasizes the importance of an anti-inflammatory, is it possible to compounding eye drops using sodium diclofenac?

Is the bubble point test a mandatory final check that must always be performed when preparing eye drops, such as those containing atropine sulfate where a sterile filter is used?

What are the differences in efficacy and absorption between tetracaine base and tetracaine HCl, are there studies available on this, and why is the base form unavailable in Belgium (though available in Germany), specifically for preparing a mucosal numbing ointment for dry needling?

Is it still permissible for internal use to have propylene glycol present in aqua conservans, which is used in morphine syrups and pseudoephedrine syrup for children (NF VI)?